Booster Shots

Oddities, musings and some news from the world of health.

| Main |

A deep breath and a closer look at statins

10:17 AM, November 24, 2008

In a healthy heart, shown here in an angiogram, blood flows freely.

The dust is settling in the wake of the newest heralded study about statins, with doctors and patients alike now taking stock of what the results should mean in real life.

To recap, from the L.A. Times: Statins may benefit healthy people too

"In results from an eagerly anticipated study that could dramatically change the treatment of cardiovascular disease, researchers have found that statin drugs -- now given to millions of people with high cholesterol -- can halve the risk of heart attacks and stroke in seemingly healthy patients as well."

The results, promising and provocative as they were, received much media attention. But, as with most headline-fodder topics, they've also led to questions:

From NPR's "Talk of the Nation": Should healthy people take statins?

"A study in the New England Journal of Medicine suggests that the drug Crestor, typically used for reducing cholesterol levels, may reduce the risk of heart disease for people with normal cholesterol levels. But do the potential benefits offset the risks and cost of the drugs?" A discussion with Dr. Paul Ridker of Harvard Medical School and Dr. Mark Hlatky of Stanford University.

From the New York Times' Tara Parker-Pope: A call for caution in the rush to statins

"Is it time to put cholesterol-lowering statin drugs in every medicine cabinet? Judging by recent headlines, you might think so."

From Toronto's Globe and Mail: When it comes to statins, don't believe the hype

"The principal finding in this study was that participants who took a statin pill recorded a 50 percent reduction in the risk of heart attack, stroke, surgery and death compared with those who took a placebo (a sugar pill). Who wouldn't be wowed by those numbers? Who wouldn't want that miracle drug? But the benefits are relative risk reductions."

And from the Consumer Reports' blogs: Heart-attack prevention: Statins aren't for everybody

Says Dr. Marvin Lipman in response to his patients' question "Should I immediately start taking a statin?" "Probably not, at least based on this study."

The L.A. Times Health section will offer a closer look at statins and cholesterol in the coming weeks, but for now, these logical questions and measured responses are worth a read or, in the case of NPR, a listen.

-- Tami Dennis

Photo: In a healthy heart, shown here in an angiogram, blood flows freely. But cholesterol can lead to a buildup of plaque in the arteries, impeding blood flow. That's where cholesterol-lowering drugs called statins come in. Credit: Custom Medical Stock Photo

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c630a53ef0105361d6a22970c

Listed below are links to weblogs that referenceA deep breath and a closer look at statins :

Comments
Post a comment
If you are under 13 years of age you may read this message board, but you may not participate.
Here are the full legal terms you agree to by using this comment form.

Comments are moderated, and will not appear until they've been approved.

If you have a TypeKey or TypePad account, please Sign In





ADVERTISEMENT


Our Bloggers
Tami Dennis, who takes the word "skeptic" to previously uncharted territory, is the Times' Health and Science editor. She's adamant that pitches promoting awareness days, weeks or months are, by their nature, non-stories. And, because she's an adult, she refuses to use words like "veggies," "tummy" and "yummy."
Rosie Mestel, deputy Health and Science editor, studied genetics before abandoning flies, fungi and DNA for health/medical writing. Her hero is the biologist Ernst Haeckel, whose jellyfish paintings inspired snazzy chandeliers. Her favorite toast-spread is Marmite, a British delicacy made of yeast extract. Her least-favorite word is "millenniums."
Melissa Healy is a staff writer for the Health section reporting from Washington D.C. Healy's a veteran of The Times' National staff, having covered the Pentagon, Congress, poverty and social welfare, the environment, and the White House before shifting to Health in 2003. She writes frequently about mental health and human behavior, about federal health policy, prescription medication and ethics in medicine. More wonk than wellness freak, Healy chooses to believe in the health benefits of coffee and wine, and considers water a better work-out medium than beverage.
Karen Kaplan covers genetics, stem cells and cloning. She and colleague Thomas H. Maugh II comprise about 25% of the unofficial MIT-Alumni-in-Journalism Club, and she is proud to have taken more math (5) than English (0) courses in college. Her contributions to Booster Shots will, she hopes, appear more frequently than postings to her mommy blog.
Thomas H. Maugh II has been a science and medical writer at the Times for 23 years. Before that, he was on the staff of the journal Science for 13 years. He has bachelor's degrees in English and chemistry from MIT and a doctorate in chemistry from UC Santa Barbara.
After a brief stint as a sports writer, Shari Roan turned to health journalism and has covered the topic for The Times for 18 years. She is the author of three books and the mother of two daughters, both teenagers who refer to her as a "health freak." She likes to jog, watch baseball and is very happy that dark chocolate contains some health benefit.
Jeannine Stein writes about fitness, sports medicine and obesity for the Health section. She’s a gym rat from way back and never met an elliptical trainer she didn’t like. Well, maybe one or two. She tempers exercise with a steady diet of reality television because she believes it’s all about balance.